Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis
On Oct. 13, 2025, researchers from Texas A&M University announced they have identified two estrogens, estradiol and estriol,…
FDA Approves Ocrevus Zunovo™ as the First and Only Twice-A-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
On Sept. 13, 2024, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Ocrevus Zunovo™…
U.S. FDA approved first biosimilar to treat Multiple Sclerosis
On Aug. 24, 2023, the U.S. Food and Drug Administration approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar to…
New landmark Nature study provided long-sought mechanistic link between EBV and Multiple Sclerosis
On Jan. 24, 2022, Atara Biotherapeutics, a leader in T-cell immunotherapy, announced that it had leveraged its novel…
NIH scientists discovered new B cell that tempers autoimmunity
On Dec. 2, 2021, researchers at the National Eye Institute (NEI) announced they had identified, isolated, and characterized…
FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
On Jul. 29, 2021, BOTOX(R) Allergan, an AbbVie company, announced that the U.S. Food and Drug Administration (FDA)…
BioNTech published data on novel mRNA vaccine approach to treat autoimmune diseases in Science
On Jan. 7, 2021, BioNTech announced publication of preclinical data on its novel mRNA vaccine approach against autoimmune…
Genentech drug Ocrevus (ocrelizumab) was approved
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
University of British Columbia researchers discovered a genetic link to multiple sclerosis
On Jun. 1, 2016, scientists at the University of British Columbia and Vancouver Coastal Health announced proof that…
Governor Mary Fallin dedicated OMRF’s new 186,000 square foot research tower
On Apr. 21, 2011, Governor Mary Fallin dedicated the Oklahoma Medical Research Foundation’s (OMRF) new 186,000 s.f. research…
OMRF’s Multiple Sclerosis Center of Excellence opened its doors
On Mar. 15, 2011, the Oklahoma Medical Research Foundation’s Multiple Sclerosis Center of Excellence, led by Dr. Gabriel…
Sanofi-aventis acquired Genzyme for $21 billion
On Feb. 15, 2011, Sanofi-aventis announced it would acquired Genzyme for $74 a share in cash or $21.1…
UCSF researchers discovered that B cells orchestrate the inflammation of myelin that causes multiple sclerosis
In 2008, University of California, San Francisco (UCSF) researchers discovered that B cells orchestrate the inflammation of myelin…
Research caused concern that hepatitis B vaccination might be linked with multiple sclerosis
In 1998, some research caused concern that hepatitis B vaccination might be linked with multiple sclerosis (MS), a…
Biotechnology | Disease | FDA | Therapeutics
FDA approved Betaseron, the first of several biotech products that have had a major impact on multiple sclerosis treatment
On Jul. 23, 1993, the U.S. Food and Drug Administration (FDA) approved Bayer’s Betaseron, the first of several…
Chiron’s Betaseron was approved as the first treatment for multiple sclerosis in 20 years
On Jul. 23, 1993, Chiron and Berlex Laboratories announced that the U.S. Food and Drug Administration (FDA) had…
Biotechnology | Diagnostics | HIV | NIH | Therapeutics
The first AIDS patient seen at the NIH was admitted
On Jun. 16, 1981, Dr. Thomas Waldmann helped treat the first patient with AIDS. In 2016, the Food…